secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001193125-22-211859
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology delays Q2 2022 earnings release to Aug 9, 2022 to finalize results
--------------------------------------------------------------------------------

- Company will issue Q2 2022 earnings release on August 9, 2022 after market close.
- Delay allows additional time to finalize financial results for the quarter ended June 30, 2022.
- Quarterly Report on Form 10-Q remains scheduled for filing on or before its due date of August 9, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312522211859/0001193125-22-211859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312522211859/d389021d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-211859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer